Several signaling pathways have been identified as upstream regulators for activation of EMT in cancers, including Wnt, Notch, TGFβ, PI3K/AKT/mTOR, JAK/STAT, and hypoxia/HIF-1α signaling pathways [40,56]. Here, AKT1 is linked to cancer.